EUVIMEDEUVIMED entdecken
Crossref

Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes

Steffi De Meyer iD, Elena R Blujdea, Jolien Schaeverbeke, Mariska Reinartz iD, Emma S Luckett iD, Katarzyna Adamczuk, Koen Van Laere, Patrick Dupont, Charlotte E Teunissen iD, Rik Vandenberghe iD, Koen Poesen iD

Brain · 01.03.2024 · 147 (3) · 936-948

DOI: 10.1093/brain/awad330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 03.10.2023. Verfasst von Steffi De Meyer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Alzheimer's Association, Dutch Research Council, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood-based biomarkers have been extensively evaluated for their diagnostic potential in Alzheimer’s disease. However, their relative prognostic and monitoring capabilities for cognitive decline, amyloid-β (Aβ) accumulation and grey matter loss in cognitively unimpaired elderly require further investigation over extended time periods. This prospective cohort study in cognitively unimpaired elderly [n = 185, mean age (range) = 69 (53–84) years, 48% female] examined the prognostic and monitoring capabilities of glial fibrillary acidic protein (GFAP), neurofilament light (NfL), Aβ1-42/Aβ1-40 and phosphorylated tau (pTau)181 through their quantification in serum. All participants underwent baseline Aβ-PET, MRI and blood sampling as well as 2-yearly cognitive testing. A subset additionally underwent Aβ-PET (n = 109), MRI (n = 106) and blood sampling (n = 110) during follow-up [median time interval (range) = 6.1 (1.3–11.0) years]. Matching plasma measurements were available for Aβ1-42/Aβ1-40 and pTau181 (both n = 140). Linear mixed-effects models showed that high serum GFAP and NfL predicted future cognitive decline in memory (βGFAP×Time = −0.021, PFDR = 0.007 and βNfL×Time = −0.031, PFDR = 0.002) and language (βGFAP×Time = −0.021, PFDR = 0.002 and βNfL×Time = −0.018, PFDR = 0.03) domains. Low serum Aβ1-42/Aβ1-40 equally but independently predicted memory decline (βAβ1-42/Aβ1-40×Time = −0.024, PFDR = 0.02). Whole-brain voxelwise analyses revealed that low Aβ1-42/Aβ1-40 predicted Aβ accumulation within the precuneus and frontal regions, high GFAP and NfL predicted grey matter loss within hippocampal regions and low Aβ1-42/Aβ1-40 predicted grey matter loss in lateral temporal regions. Serum GFAP, NfL and pTau181 increased over time, while Aβ1-42/Aβ1-40 decreased only in Aβ-PET-negative elderly. NfL increases associated with declining memory (βNfLchange×Time = −0.030, PFDR = 0.006) and language (βNfLchange×Time = −0.021, PFDR = 0.02) function and serum Aβ1-42/Aβ1-40 decreases associated with declining language function (βAβ1-42/Aβ1-40×Time = −0.020, PFDR = 0.04). GFAP increases associated with Aβ accumulation within the precuneus and NfL increases associated with grey matter loss. Baseline and longitudinal serum pTau181 only associated with Aβ accumulation in restricted occipital regions. In head-to-head comparisons, serum outperformed plasma Aβ1-42/Aβ1-40 (ΔAUC = 0.10, PDeLong, FDR = 0.04), while both plasma and serum pTau181 demonstrated poor performance to detect asymptomatic Aβ-PET positivity (AUC = 0.55 and 0.63, respectively). However, when measured with a more phospho-specific assay, plasma pTau181 detected Aβ-positivity with high performance (AUC = 0.82, PDeLong, FDR < 0.007). In conclusion, serum GFAP, NfL and Aβ1-42/Aβ1-40 are valuable prognostic and/or monitoring tools in asymptomatic stages providing complementary information in a time- and pathology-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansFemaleAgedMaleGray MatterProspective StudiesAmyloid beta-Peptidestau ProteinsAmyloidBiomarkersCognitionPositron-Emission Tomography

Stichwörter der Autor:innen

blood biomarkersmonitoringpositron emission tomographypreclinical Alzheimer’s diseaseprognosis

Substanzen

Amyloid beta-Peptidestau ProteinsAmyloidBiomarkers

Autor:innen und Institutionen

  • Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.
  • Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.
  • Alzheimer Research Centre, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium.
  • Neurochemistry Laboratory, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.
  • Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.
  • Division of Nuclear Medicine, UZ Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Steffi De Meyer, Mariska Reinartz, Emma S Luckett, Charlotte E Teunissen, Rik Vandenberghe, Koen Poesen

Förderung

  • Alzheimer's Association
  • Dutch Research Council
  • ZonMw
  • Fonds Wetenschappelijk Onderzoek
  • Stichting Alzheimer Onderzoek
  • F-PACK project
  • Flanders Innovation and Entrepreneurship
  • European Joint Program for Neurodegenerative disorders

Zitieren

APA

De Meyer, S., Blujdea, E. R., Schaeverbeke, J., Reinartz, M., Luckett, E. S., Adamczuk, K., Van Laere, K., Dupont, P., Teunissen, C. E., Vandenberghe, R., & Poesen, K. (2024). Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes. Brain, 147(3), 936-948. https://doi.org/10.1093/brain/awad330

Vancouver

De Meyer S, Blujdea ER, Schaeverbeke J, Reinartz M, Luckett ES, Adamczuk K, et al. Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes. Brain. 2024;147(3):936-948. doi:10.1093/brain/awad330

BibTeX
@article{DeMeyer2024,
  author = {De Meyer, Steffi and Blujdea, Elena R and Schaeverbeke, Jolien and Reinartz, Mariska and Luckett, Emma S and Adamczuk, Katarzyna and Van Laere, Koen and Dupont, Patrick and Teunissen, Charlotte E and Vandenberghe, Rik and Poesen, Koen},
  title = {Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {3},
  pages = {936--948},
  doi = {10.1093/brain/awad330}
}
Kostenlos starten →